Prevalence of Virulence Factors and Antimicrobial Resistance of Uropathogenic Escherichia coli in Jiangsu Province (China)

Urology

Volumn 74, Issue 3, 2009, Pages 702-707

  Zhao, Lixiang ^a,b   Chen, Xiang ^a   Zhu, Xiaoping ^a   Yang, Weixia ^a   Dong, Lanmei ^a   Xu, Xiaojing ^b   Gao, Song ^a   Liu, Xiufan ^a  

^a YANGZHOU UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFOXITIN; CHLORAMPHENICOL; COTRIMOXAZOLE; ESCHERICHIA COLI PROTEIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; MEZLOCILLIN; NALIDIXIC ACID; NITROFURANTOIN; PROTEIN FEOB; PROTEIN FIMH; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CHINA; CONTROLLED STUDY; GENETIC VARIABILITY; MOLECULAR PHYLOGENY; NONHUMAN; PHENOTYPIC VARIATION; PREVALENCE; PRIORITY JOURNAL; SEROTYPING; UROPATHOGENIC ESCHERICHIA COLI;

CHINA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 69249216808     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.01.042     Document Type: Article

References (23)

1. Eisenstein B.I., and Jones G.W. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Adv Intern Med 33 (1988) 231-252
2. Boyd E.F., and Hartl D.L. Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J Bacteriol 180 (1998) 1159-1165
3. Donnenberg M.S., and Welch R.A. Virulence determinants of uropathogenic Escherichia coli. In: Mobley H.L.T., and Warren J.W. (Eds). Urinary Tract Infections (1996), ASM Press, Washington, DC 135-174
4. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4 (1991) 80-128
5. Russo T.A., Wenderoth S., Carlino U.B., et al. Identification, genomic organization, and analysis of the group III capsular polysaccharide genes kpsD, kpsM, kpsT and kpsE from an extraintestinal isolate of Escherichia coli (CP9, O4/K 54/H5). J Bacteriol 180 (1998) 338-349
6. Ling Z., Song S.Q., and Ying C.J. Amplification and identification of type I of papG gene from uropathogenic Escherichia coli. J Fujian Medical University Sinica 39 (2007) 4-10
7. Bajaj J.K., Karyakarte R.P., Kulkarni J.D., et al. Changing etiology of urinary tract infections and emergence of drug resistance as a major problem. J Commun Dis 31 (1999) 181-184
8. Chomarat M. Resistance of bacteria in urinary tract infections. Int J Antimicrob Agents 16 (2000) 483-487
9. Dyer I.E., Sankary T.M., and Dawson J.A. Antibiotic resistance in bacterial urinary tract infections, 1991-1997. West J Med 169 (1998) 265-268
10. Bukharie H.A., and Saeed I.M. Antimicrobial resistance among pathogens causing acute uncomplicated UTIs. Infect Med 18 (2001) 358-362
11. Carios R.K., Caio M., Carmen P.O., et al. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Braz J Urol 33 (2007) 42-49
12. Goldstein F.W. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur J Clin Microbiol Infect Dis 19 (2000) 112-117
13. Gupta K., Hooton T.M., and Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135 (2001) 41-50
14. Zhanel G.G., Karlowsky J.A., Harding G.K., et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprimsulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. Antimicrob Agents Chemother 44 (2000) 1089-1092
15. Dapeng Y. The drug resistance of pathogenic bacteria collected from urinary tract infection patients subjected to the Allied Hospital of Beihua University. China J Misdiagn 7 (2007) 2492-2493
16. Zhao S.B., Song L., and Hu H. Distribution of bacteria in urinary tract infection and analysis of drug resistance of these bacteria. Ningxia Med J 29 (2007) 750-752
17. Wang J., Liu H., Xuefeng Z., et al. Drug resistance supervision to pathogens from urinary tract in mountain area of western Hubei province. China J Nosocomiol 17 (2007) 732-733
18. Wan X., Wenfang W., Yu C., et al. The pathogenetic characteristics of community-acquired urinary tract infection in female in Nanjing. Jiangsu Med J 34 (2008) 571-573
19. Clermont O., Bonacorsi S., and Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66 (2000) 4555-4558
20. Rodriguez-Siek K.E., Giddings C.W., Doetkott C., et al. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 151 (2005) 2097-2110
21. Selander R.K., Korhonen T.K., Väisänen-Rhen V.P., et al. Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis. Infect Immun 52 (1986) 213-222
22. Kallenius G., Mollby R., and Svenson S.B. Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet 2 (1981) 1369-1372
23. Soto S.M., Jimenez de Anta M.T., and Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother 50 (2006) 649-653